Crohn Disease
- Rinvoq Approved for Moderately to Severely Active Crohn Disease
- Combination Therapy With Adalimumab and Methotrexate Linked to Fewer Treatment Failures in PCD
- Early Biologic Initiation for Crohn Disease Reduces Overall Health Care Costs
- Biochemical Remission in Crohn Disease Associated With Ustekinumab Levels
- Characteristics of Patients With Perianal Lesions at Time of Crohn Disease Diagnosis
- Ustekinumab Is Safe in Crohn Disease With Latent TB or Inactive Chronic HBV
- Can Mesenchymal Stem Cells Treat Perianal Fistulizing Crohn Disease?
- Crohn Disease Failure to Pass a Patency Capsule Linked to Worse Outcomes
- Body Composition and Disease Activity Correlate in Crohn Disease
- Early Ileocecal Resection in CD May Reduce Postoperative Complications
- Some Patients With Crohn Disease Require Ustekinumab Intensification Within First Year
- Etrolizumab Maintenance, but not Induction, Superior to Placebo in CD
Clinical Tools
Powered by
Powered by 
